GNPX CIK: 1595248

Genprex, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.7
FY22:
−23.8
FY23:
−31.1
FY24:
−21.2
FY25:
−15.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.6
FY22:
−23.8
FY23:
–
FY24:
−21.2
FY25:
−15.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.7
FY22:
−23.7
FY23:
–
FY24:
−21.1
FY25:
−16.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.7
FY22:
−23.7
FY23:
−30.9
FY24:
−21.1
FY25:
−16.2

All amounts in millions USD Data sources:SEC EDGARTwelve Data